Skip to main content
Tech.euFundingExplorerBeta
Funding rounds/NBE-Therapeutics

NBE-Therapeutics

Series A
Basel, SwitzerlandFounded 2012Mar 2015
Healthtech

NBE-Therapeutics raised €2.8M in a Series A round in Mar 2015. The company is based in Basel, Switzerland. Investors in the round: Boehringer Ingelheim Venture Fund. Data as of Nov 2026.

← NBE-Therapeutics
Amount raised
€2.8M
€2,800,000
Native amount
2,800,000 EUR
Stage
Series A
series a
Investors
1

Provenance & confidence

Unverified
Amount

Reported in EUR — no conversion. €2.8M

High confidence
Source

No source on record — unverified.

Unverified

Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.

Investors in this round

1 named
Boehringer Ingelheim Venture Fund
Date
Mar 2015
Round type
series a
Amount (EUR)
€2.8M

Other rounds

same company